Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Non-interventional Prospective Data Collection on Persistence and Adherence on Ticagrelor in ACS Adult Patients in Serbia

Trial Profile

Non-interventional Prospective Data Collection on Persistence and Adherence on Ticagrelor in ACS Adult Patients in Serbia

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Oct 2018

At a glance

  • Drugs Ticagrelor (Primary)
  • Indications Acute coronary syndromes
  • Focus Therapeutic Use
  • Acronyms ADHERE-S (NIS Brilique)
  • Sponsors AstraZeneca
  • Most Recent Events

    • 04 Oct 2018 Status changed from recruiting to active, no longer recruiting.
    • 18 Sep 2018 Planned End Date changed from 30 Jun 2019 to 30 Sep 2019.
    • 18 Sep 2018 Planned primary completion date changed from 30 Jun 2019 to 30 Sep 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top